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E R Francis, C Kuo, A Bernabe-Ortiz, L Nessel, R Gilman, W Checkley, J Miranda, H Feldman, and the CRONICAS Cohort Study Group
Abstract 
Background Chronic kidney disease’s (CKD) silent progression, association with other chronic diseases, and high 
treatment costs make it a global public health concern, especially in low-income and middle-income countries (LMIC) 
where health-care resources are constrained. Understanding CKD epidemiology in these countries is key to addressing 
CKD burden and will guide disease surveillance, screening, prevention, and resource allocation. In keeping, this 
study serves as one of the early descriptions of the CKD burden in Peru.
Methods In this cross-sectional study, we collected baseline demographic data and biological samples to measure 
markers for CKD, serum creatinine, and urine protein, from 404 participants who were a random subsample of the 
ongoing CRONICAS cohort study in Lima and Tumbes, Peru. Participants were identiﬁ ed via a single-stage sampling 
method and stratiﬁ ed by sex and age (35–44; 45–54; 55–64; and ≥65 years). Inclusion required full-time residence 
in the area, the ability to understand study procedures, and informed consent. Selection of participants continued 
until age and sex strata were ﬁ lled. Trained ﬁ eldworkers went door-to-door to enrol selected participants and receive 
written informed consent. We used Poisson regression to identify possible factors associated with CKD. CKD was 
deﬁ ned as estimated glomerular ﬁ ltration rate (eGFR) <60mL/min/1·73m² or proteinuria (protein-creatinine ratio) 
≥150 mg/g creatinine, or both, based on the latest Kidney Disease Improving Global Outcomes (KDIGO) guideline.
Findings Participants’ median age was 54·8 years (IQR 44·9–64·8). Of the 404 participants, 68 (16·8%) met the study’s 
CKD criteria: 60 (14·9%) with proteinuria, four (1%) with eGFR <60mL/min/1·73m², and four (1%) with both. CKD 
prevalence was higher in Lima than Tumbes (20·7% vs 12·9%, p=0·04). Among participants with CKD, the prevalence 
of diabetes and hypertension was 19·1% (n= 13) and 42·7% (29), respectively. After multivariable adjustment, CKD was 
associated with older age, female sex, the highest wealth tertile (although all wealth strata were below the poverty line), 
living in Lima, diabetes, and hypertension.
Interpretation This study has identiﬁ ed a high prevalence of CKD in our Lima and Tumbes sample groups. Our 
ﬁ ndings highlight the burden of CKD, much of which is likely occult, and suggest that expanded strategies to measure 
actual CKD burden through nationwide surveillance eﬀ orts are needed. In light of the few therapeutic options to slow 
CKD progression and low rates of access to health care and insurance in Peru, such expanded surveillance strategies 
may identify more disease and, therefore, help to prevent disease progression and secondary morbidity. 
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